Feedback / Questions
Elayta (zervimesine) - Cognition Therap
https://www.globenewswire.com/news-release/2025/07/01/3108233/0/en/Cognition-Therapeutics-Study-of-Zervimesine-CT1812-in-Early-Alzheimer-s-Disease-Surpasses-50-Enrollment-Target.html
Jul 1, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next